Prestige Consumer Healthcare (PBH) Fails to deliver data

Key failure to deliver metrics for Prestige Consumer Healthcare:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: £2.28 M
• Last 12 months FTD volume: £4.55 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Prestige Consumer Healthcare (PBH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Prestige Consumer Healthcare (PBH) - since 2013

Prestige Consumer Healthcare (PBH) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	£61.56 M	£0.39 B	🇬🇧 UK
Pfizer PFE	£29.26 M	£0.10 B	🇺🇸 USA
Rite Aid RAD	£12.18 M	£30.91 M	🇺🇸 USA
Johnson & Johnson JNJ	£57.52 M	£0.10 B	🇺🇸 USA
Taro Pharmaceutical TARO	N/A	£0.62 M	🇮🇱 Israel
Novartis NVS	£19.76 M	£75.6 M	🇨🇭 Switzerland
Procter & Gamble PG	£32.75 M	£0.33 B	🇺🇸 USA
CVS Health CVS	£31.25 M	£0.18 B	🇺🇸 USA
Clorox CLX	£14.86 M	£94.87 M	🇺🇸 USA
Abbott Laboratories ABT	£34.98 M	£0.43 B	🇺🇸 USA